NEW YORK (GenomeWeb) – PerkinElmer said after the close of the market on Thursday that its first quarter revenues were up 5 percent year over year.

The Waltham, Mass.-based company said that for the three months ended March 30, revenues grew to $531.9 million from $505.4 million in the year-ago quarter, edging out the consensus analyst estimate of $531.3 million.

Its Human Health segment posted a 6 percent increase in revenue year over year to $299.5 million from $281.3 million, while its Environmental Health segment grew 4 percent to $232.4 million from $224.0 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.